The Study Collect Clinical Data From the Treatment of Liver Cancer With New Drugs After 2019 and Integrate Biochemical and Pathological Indicators to Analyze Prognostic Outcomes, Including Overall Survival, Progression-free Survival, and Complications.
Clinical trial NCT07233759 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07233759
- Sponsor
- National Taiwan University Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-01-31
- Primary completion
- 2026-12-31
- Enrollment
- 2500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.